GSK Appeals Mylan Trial Victory Over Generic Paxil Deal
GlaxoSmithKline PLC has asked the Third Circuit to review a New Jersey federal jury's $106.7 million judgment against the pharmaceutical giant for allowing Apotex Inc. to sell generic versions of Paxil...To view the full article, register now.
Already a subscriber? Click here to view full article